WNDM Medical Inc (WNDM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:WNDM Medical Inc (WNDM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8036
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone bleeding. Its product finds application in all except third degree burns, acute wounds, and chronic wounds. WNDM Medical discovers, develops, and markets advanced wound care products. The company has license agreement with Applied Nutritional for patented technologies and processes related to CellerateRX. It markets its products through independent distributors, healthcare distributors, distributor organizations, and sales representatives. WNDM Medical is headquartered in Fort Worth, Texas, the US.

WNDM Medical Inc (WNDM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WNDM Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
WNDM Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Wound Management Technologies Raises USD0.2 Million in Rights Offering of Shares 11
Wound Management Technologies Announces Private Placement Of Shares For US$2.4 Million 12
Debt Offering 13
Wound Management Technologies Raises USD0.5 Million in Private Placement of 10% Notes 13
Wound Management Technologies Raises USD0.4 Million in Public Offering of Debentures Due 2015 14
WNDM Medical Inc – Key Competitors 15
WNDM Medical Inc – Key Employees 16
WNDM Medical Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Recent Developments 19
Financial Announcements 19
Jul 12, 2018: WNDM Medical Announces Record Sales for the Second Quarter of 2018 – Up 56% over Second Quarter 2017 19
Mar 29, 2018: Wound Management Technologies Announces Record Annual Sales Ending December 31, 2017 – Up 14% over 2016 20
Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter 21
May 17, 2017: Wound Management Issues 2017 10Q and Hires New Strategic Marketing Director 22
Apr 27, 2017: Q1 2017 Sales Up 32% Over Q1 2016, for Wound Management Technologies 23
Feb 14, 2017: Wound Management Technologies Announces Record Quarterly and Annual Sales Ending December 31, 2016 – Up 147% over Q4 2015, and 63% over 2015 24
Corporate Communications 25
Feb 15, 2018: Wound Management Technologies Announces J. Michael Carmena Appointed Chief Executive Officer 25
Mar 08, 2017: Wound Management announces appointment of John Siedhoff as Chairman 26
Other Significant Developments 27
Apr 03, 2018: Wound Management Technologies Changes Name to WNDM Medical 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
WNDM Medical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WNDM Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WNDM Medical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
WNDM Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Wound Management Technologies Raises USD0.2 Million in Rights Offering of Shares 11
Wound Management Technologies Announces Private Placement Of Shares For US$2.4 Million 12
Wound Management Technologies Raises USD0.5 Million in Private Placement of 10% Notes 13
Wound Management Technologies Raises USD0.4 Million in Public Offering of Debentures Due 2015 14
WNDM Medical Inc, Key Competitors 15
WNDM Medical Inc, Key Employees 16
WNDM Medical Inc, Subsidiaries 17
WNDM Medical Inc, Joint Venture 17

List of Figures
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
WNDM Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[WNDM Medical Inc (WNDM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Canyon Services Group Inc. (FRC):企業の財務及び戦略的SWOT分析
    Summary Canyon Services Group Inc. (Canyon) is an oilfield service provider that offers hydraulic fracturing and other well-stimulation services. The company’s equipment fleet includes equipment fleet, hydraulic fracturing equipment, coiled tubing equipment, acidizing equipment, remedial cementing e …
  • C&J Energy Services Inc (CJ):企業の財務・戦略的SWOT分析
    C&J Energy Services Inc (CJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Oxford Advanced Surfaces Group Plc (OXA):企業概要、財務及び戦略的SWOT分析
    Summary Oxford Advanced Surfaces Group Plc (OAS) is a research and development company. The company designs, develops and manufactures advanced materials for surface modification, adhesion promotion and nano material applications. Its products include Onto EP1000. OAS’ proprietary platform technolog …
  • Galadari Hotels (Lanka) PLC:企業の戦略・SWOT・財務分析
    Galadari Hotels (Lanka) PLC - Strategy, SWOT and Corporate Finance Report Summary Galadari Hotels (Lanka) PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Thornton & Ross Ltd:企業のM&A・提携動向(医療分野)
    Summary Thornton & Ross Ltd (Thornton and Ross), a subsidiary of Stada Arzneimittel AG is a pharmaceutical company that develops and supplies medicines and healthcare products. The company manufactures over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and …
  • Essilor International S.A.:企業の戦略・SWOT・財務分析
    SummaryEssilor International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Biosensors International Group Ltd:企業のM&A・提携動向(医療機器分野)
    Summary Biosensors International Group Ltd (Biosensors) is a medical devices company. It develops, manufactures and markets medical devices. The company products find application in Interventional cardiology and critical care procedures. The company classifies its products into four categories: Inte …
  • HeidelbergCement AG:企業のM&A・事業提携・投資動向
    HeidelbergCement AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HeidelbergCement AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Lombard Odier:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Lombard Odier" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a s …
  • Bilcare Ltd.の企業概要及び財務/SWOT分析
    Bilcare Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Bilcare Ltd. annual and quarterly forecasts made by stock market experts. The report also enables direct comparis …
  • Electrovaya Inc. (EFL)-エネルギー分野:企業M&A・提携分析
    Summary Electrovaya Inc. (Electrovaya) is a vertically integrated energy storage solutions company which designs, develops, manufactures, and markets power technology products. Its offerings include lithium ion super polymer batteries, battery systems, and battery related products and accessories. T …
  • Asian Infrastructure Investment Bank:電力:M&Aディール及び事業提携情報
    Summary Asian Infrastructure Investment Bank (AIIB) is a multilateral financial institution. The company develops infrastructure and other productive sectors. It provides sovereign and non-sovereign finance for sustainable projects in energy and power, transportation and telecommunications, rural in …
  • The Maryland Technology Development Corp:企業のM&A・事業提携・投資動向
    The Maryland Technology Development Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Maryland Technology Development Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • KPJ Healthcare Berhad (KPJ):企業の財務・戦略的SWOT分析
    Summary KPJ Healthcare Berhad (KPJ) is a healthcare service provider that offers medical services. The center offers services in the areas of anaesthesiology, cardiology and cardiothoracic surgery, child psychiatry, clinic pathology, occupational health services, orthopaedic and trauma surgery, diet …
  • MNRB Holdings Berhad:企業の戦略・SWOT・財務情報
    MNRB Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary MNRB Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Teijin Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Teijin Limited Mergers and Acqu …
  • Eni SpA (ENI):石油・ガス:M&Aディール及び事業提携情報
    Summary Eni SpA (Eni) is an integrated oil and gas company that carries out oil and natural gas exploration, field development and production activities. It is also involved in supply, trading and shipping of natural gas, LNG, electricity and fuels. The company has operations in Italy, Cyprus, the U …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • PharmaEngine Inc (4162):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaEngine Inc (PharmaEngine) is a biopharmaceutical company that discovers and develops cancer treatment drugs and related medicinal products. The company develops drugs for the treatment of cancer and Asian prevalent diseases. Its products include Onivyde a liposome encapsulation of irin …
  • L’Oreal S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' L'Oreal S.A. Mergers and Acquis …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆